Karunya Albert

Dr. Karunya Albert


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Advances in Colloid and Interface Science
Verified
Journal Article
Closed access
KAKarunya Albert
Karunya Albert
XHXin-Chun Huang
Xin-Chun Huang
HHHsin-Yun Hsu
Hsin-Yun Hsu

20 November 2016 in Molecules
Verified
Journal Article
Open access
PDF file
KAKarunya Albert
Karunya Albert
HHHsin-Yun Hsu
Hsin-Yun Hsu
Carbon-based nanomaterials serve as a type of smart material for photo-triggered disease theranostics. The inherent physicochemical properties of these nanomaterials facilitate their use for less invasive treatments. This review summarizes the properties and applications of materials including fullerene, nanotubes, nanohorns, nanodots and nanographenes for photodynamic nanomedicine in cancer and antimicrobial therapies. Carbon nanomaterials themselves do not usually act as photodynamic therapy (PDT) agents owing to the high hydrophobicity, however, when the surface is passivated or functionalized, these materials become great vehicles for PDT. Moreover, conjugation of carbonaceous nanomaterials with the photosensitizer (PS) and relevant targeting ligands enhances properties such as selectivity, stability, and high quantum yield, making them readily available for versatile biomedical applications.

31 October 2023 in Journal of Extracellular Vesicles
Verified
Journal Article
Open access
JZJingjing Zhang
Jingjing Zhang
XRXilal Y. Rima
Xilal Y. Rima
Xinyu WangXinyu Wang
Xinyu Wang
LNLuong T. H. Nguyen
Luong T. H. Nguyen
KHKristin Huntoon
Kristin Huntoon
EREduardo Reátegui
Eduardo Reátegui
The molecular heterogeneity of extracellular vesicles (EVs) and the co‐isolation of physically similar particles, such as lipoproteins (LPs), confounds and limits the sensitivity of EV bulk biomarker characterization. Herein, we present a single‐EV and particle (siEVP) protein and RNA assay (siEVPPRA) to simultaneously detect mRNAs, miRNAs, and proteins in subpopulations of EVs and LPs. The siEVPPRA immobilizes and sorts particles via positive immunoselection onto micropatterns and focuses biomolecular signals in situ. By detecting EVPs at a single‐particle resolution, the siEVPPRA outperformed the sensitivities of bulk‐analysis benchmark assays for RNA and protein. To assess the specificity of RNA detection in complex biofluids, EVs from various glioma cell lines were processed with small RNA sequencing, whereby two mRNAs and two miRNAs associated with glioblastoma multiforme (GBM) were chosen for cross‐validation. Despite the presence of single‐EV‐LP co‐isolates in serum, the siEVPPRA detected GBM‐associated vesicular RNA profiles in GBM patient siEVPs. The siEVPPRA effectively examines intravesicular, intervesicular, and interparticle heterogeneity with diagnostic promise.

1 February 2020 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
KAKarunya Albert
Karunya Albert
PHPei-Ying Hsieh
Pei-Ying Hsieh
TCTsai-Hsuan Chen
Tsai-Hsuan Chen
Chia-Hung HouChia-Hung Hou
Chia-Hung Hou
HHHsin-Yun Hsu
Hsin-Yun Hsu

30 October 2013 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
KAKarunya Albert
Karunya Albert
CRC. Rose
C. Rose
CNC. Valli Nachiyar
C. Valli Nachiyar

1 April 2017 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
HCHau-Yun Chen
Hau-Yun Chen
KAKarunya Albert
Karunya Albert
CWCheng-Che Wen
Cheng-Che Wen
PHPei-Ying Hsieh
Pei-Ying Hsieh
SCSih-Yu Chen
Sih-Yu Chen
HHHsin-Yun Hsu
Hsin-Yun Hsu